Hip Fractures, Osteoporosis
Conditions
Keywords
All NC LTC facilities having ten residents with a hip fracture or osteoporosis on the MDS will be invited to participate in the trial
Brief summary
Osteoporotic fractures of the hip are a major cause of admission to long-term care facilities. Such fractures put patients at high risk for further fractures, pain and disability. Current data show that many patients in long-term care facilities do not receive FDA medications for their osteoporosis. This trial will test whether a multi-model intervention (which provides feedback about provider use of osteoporosis medications, information about osteoporosis, and currently approved osteoporosis medications)directed at physicians, other health care providers, and nurses will improve the number of prescriptions written for FDA approved medications for osteoporosis treatment.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Any North Carolina long-term care facility with ten residents who had had a hip fracture or osteoporosis diagnosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of new prescriptions for FDA-Approved osteoporosis medications. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Outcome Measures: Changes in number of bone mineral density test ordered, change in the number of hip protectors issued, change in the number of prescriptions for calcium and vitamin D, changes in the rate of new osteoporotic fractures. | — |
Countries
United States